JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $88,430 | -79.1% | 47,800 | -87.4% | 0.00% | -100.0% |
| Q4 2022 | $422,355 | -36.4% | 380,500 | +34.1% | 0.00% | -50.0% |
| Q3 2022 | $664,000 | -31.6% | 283,800 | -11.5% | 0.00% | -33.3% |
| Q2 2022 | $971,000 | -56.2% | 320,500 | -1.8% | 0.00% | -50.0% |
| Q1 2022 | $2,217,000 | -49.5% | 326,500 | -37.9% | 0.01% | -45.5% |
| Q4 2021 | $4,388,000 | +56.9% | 525,500 | +39.6% | 0.01% | +57.1% |
| Q3 2021 | $2,797,000 | +89.0% | 376,500 | +73.0% | 0.01% | +75.0% |
| Q2 2021 | $1,480,000 | +74.1% | 217,600 | +162.8% | 0.00% | +100.0% |
| Q1 2021 | $850,000 | +385.7% | 82,800 | +227.3% | 0.00% | +100.0% |
| Q2 2020 | $175,000 | -25.5% | 25,300 | -48.8% | 0.00% | 0.0% |
| Q1 2020 | $235,000 | -77.2% | 49,400 | -58.2% | 0.00% | -50.0% |
| Q4 2019 | $1,031,000 | +119.8% | 118,100 | -16.2% | 0.00% | +100.0% |
| Q3 2019 | $469,000 | -37.6% | 140,900 | -7.2% | 0.00% | -50.0% |
| Q2 2019 | $752,000 | -37.4% | 151,900 | -21.6% | 0.00% | -33.3% |
| Q1 2019 | $1,202,000 | +33.4% | 193,800 | -27.5% | 0.00% | +50.0% |
| Q4 2018 | $901,000 | -33.3% | 267,400 | +28.7% | 0.00% | -33.3% |
| Q3 2018 | $1,350,000 | +124.6% | 207,700 | +164.6% | 0.00% | +50.0% |
| Q2 2018 | $601,000 | – | 78,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 662,063 | $10,315,000 | 30.07% |
| Omega Fund Management, LLC | 579,650 | $9,031,000 | 5.11% |
| Casdin Capital, LLC | 399,825 | $6,229,000 | 1.76% |
| Cormorant Asset Management, LP | 359,738 | $5,605,000 | 0.99% |
| Foresite Capital Management II, LLC | 119,912 | $1,868,000 | 0.76% |
| Redmile Group, LLC | 955,598 | $14,888,000 | 0.73% |
| PFM Health Sciences, LP | 1,727,997 | $26,922,000 | 0.53% |
| Fosun International Ltd | 285,960 | $4,455,000 | 0.44% |
| Partner Investment Management, L.P. | 14,265 | $222,000 | 0.21% |
| Spark Investment Management LLC | 162,200 | $2,527,000 | 0.14% |